191 related articles for article (PubMed ID: 33504211)
1. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
Nofal A; Alakad R; Fouda I; Fawzy MM
J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
[TBL] [Abstract][Full Text] [Related]
2. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
Nofal A; El-Arab RE; Nasr M; Alakad R
J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Intralesional
Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
[TBL] [Abstract][Full Text] [Related]
4. Intralesional antigen immunotherapy for the treatment of plane warts: A comparative study.
Fawzy MM; Nofal A; Alakad R
Dermatol Ther; 2020 Nov; 33(6):e13807. PubMed ID: 32530550
[TBL] [Abstract][Full Text] [Related]
5. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
6. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
Nofal A; Alakad R
J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
[TBL] [Abstract][Full Text] [Related]
7. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
[TBL] [Abstract][Full Text] [Related]
8. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
9. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
Rageh RM; Hewedy ES; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
[TBL] [Abstract][Full Text] [Related]
10. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
Nofal A; Adel L; Fawzy M; Elkholy BM
Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
[TBL] [Abstract][Full Text] [Related]
11. Intralesional immunotherapy of plantar warts: report of a new antigen combination.
Gamil H; Elgharib I; Nofal A; Abd-Elaziz T
J Am Acad Dermatol; 2010 Jul; 63(1):40-3. PubMed ID: 20462659
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
Nofal A; Nofal E; Yosef A; Nofal H
Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
[TBL] [Abstract][Full Text] [Related]
13. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
Horn TD; Johnson SM; Helm RM; Roberson PK
Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380
[TBL] [Abstract][Full Text] [Related]
14. Significance of interferon gamma in the prediction of successful therapy of common warts by intralesional injection of Candida antigen.
Nofal A; Marei A; Amer A; Amen H
Int J Dermatol; 2017 Oct; 56(10):1003-1009. PubMed ID: 28791682
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
16. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.
Johnson SM; Roberson PK; Horn TD
Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of doughnut warts with intralesional Candida antigen immunotherapy.
Nofal A; Fouda I; Aboelwafa H; Fawzy MM
J Cosmet Dermatol; 2021 Jan; 20(1):295-299. PubMed ID: 32432375
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
[TBL] [Abstract][Full Text] [Related]
19. Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts.
Nofal AA; Elkholy BM; Abd-Elmonsef ER; Nofal HO
Dermatol Ther (Heidelb); 2022 May; 12(5):1225-1237. PubMed ID: 35449500
[TBL] [Abstract][Full Text] [Related]
20. Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts.
Tawfik NZ; Eyada MMK; Abdel El Hamid RE; Halim HM
Dermatol Ther; 2022 Oct; 35(10):e15762. PubMed ID: 36056784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
